Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CSL Behring | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
In a former study, the investigator observed significant differences in the response to pulmonary rehabilitation between COPD patients with the "normal" genetic variant of alpha-1 antitrypsin (PiMM) and those with a homozygous deficient variant (PiZZ) (Jarosch et al., 2016, DOI: 10.1159/000449509). PiZZ COPD patients showed less improvement in exercise capacity compared to PiMM patients. This latter finding was mirrored by an increase of oxidative myofiber type I proportion - that is important for aerobic exercises in daily life - in PiMM but not PiZZ patients.
Based on this finding of impaired skeletal muscle adaptation, the aim of this study is to compare the effects of pulmonary rehabilitation including exercise training on a) specific enzymes of energy metabolism reflecting the oxidative capacity of the skeletal muscle and b) the analogue gene expression of these oxidative enzymes in a cohort of PiMM and PiZZ COPD patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PiMM patients | Active Comparator | COPD patients with the Alpha-1 antitrypsin genetic variant "PiMM" (Smoking-related COPD) |
|
| PiZZ patients | Experimental | COPD patients with alpha-1 antitrypsin deficiency (genotype PiZZ) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pulmonary rehabilitation | Procedure | 3-weeks of inpatient pulmonary Rehabilitation including exercise Training (daily endurance and strength Training) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Endurance time | Will be measured during a constant work rate cycling test | 3 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Myofibre type I Distribution | Skeletal muscle sample will be taken from the M.vastus lateralis via Bergström muscle biopsy needle | 3 weeks |
| Capillary to fibre ratio | Skeletal muscle sample will be taken from the M.vastus lateralis via Bergström muscle biopsy needle |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Inga Jarosch | Contact | +49865293 | 1730 | ijarosch@schoen-kliniken.de |
| Name | Affiliation | Role |
|---|---|---|
| Klaus Kenn, Prof. | Department of respiratory medicine, Schoen Klinik Berchtesgadener Land | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Schoen Klinik Berchtesgadener Land | Recruiting | Schönau am Königssee | 83471 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D019896 | alpha 1-Antitrypsin Deficiency |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 weeks |
| muscle strength | strength test in the right knee Extensor and flexor | 3 weeks |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D013352 | Subcutaneous Emphysema |
| D004646 | Emphysema |